Exact Therapeutics AS banner
E

Exact Therapeutics AS
OSE:EXTX

Watchlist Manager
Exact Therapeutics AS
OSE:EXTX
Watchlist
Price: 1.76 NOK Market Closed
Market Cap: kr111.3m

Exact Therapeutics AS
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Exact Therapeutics AS
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
E
Exact Therapeutics AS
OSE:EXTX
Other
-kr10.1m
CAGR 3-Years
-38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Other
-kr20.5m
CAGR 3-Years
N/A
CAGR 5-Years
-19%
CAGR 10-Years
13%
U
Ultimovacs ASA
OSE:ULTI
Other
-kr208k
CAGR 3-Years
74%
CAGR 5-Years
62%
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Other
-kr11.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Other
-kr534k
CAGR 3-Years
N/A
CAGR 5-Years
17%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Other
-kr17.1m
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
N/A
No Stocks Found

Exact Therapeutics AS
Glance View

Market Cap
111.3m NOK
Industry
Biotechnology

EXACT Therapeutics AS is a clinical stage biopharmaceutical company, which engages in the research and development of novel platform for ultrasound mediated therapeutic amplification. The company is headquartered in Oslo, Oslo and currently employs 8 full-time employees. The company went IPO on 2020-07-14. ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within cancer (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The firm's purpose is to extend and enrich patient lives through targeted therapeutic enhancement. The company is done through harnessing the power of ultrasound in combination with ACT formulation.

EXTX Intrinsic Value
1.57 NOK
Overvaluation 11%
Intrinsic Value
Price
E

See Also

What is Exact Therapeutics AS's Other?
Other
-10.1m NOK

Based on the financial report for Dec 31, 2024, Exact Therapeutics AS's Other amounts to -10.1m NOK.

What is Exact Therapeutics AS's Other growth rate?
Other CAGR 3Y
-38%

Over the last year, the Other growth was -705%. The average annual Other growth rates for Exact Therapeutics AS have been -38% over the past three years .

Back to Top